Chemed Corporation $CHE Holdings Lowered by Gabelli Funds LLC

Gabelli Funds LLC cut its position in shares of Chemed Corporation (NYSE:CHE) by 8.3% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 31,138 shares of the company’s stock after selling 2,813 shares during the quarter. Gabelli Funds LLC’s holdings in Chemed were worth $11,762,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Monetary Solutions Ltd purchased a new stake in shares of Chemed in the 4th quarter valued at approximately $25,000. Los Angeles Capital Management LLC purchased a new position in Chemed during the 4th quarter worth approximately $26,000. BOK Financial Private Wealth Inc. acquired a new stake in Chemed during the 4th quarter valued at $27,000. Global Retirement Partners LLC raised its stake in Chemed by 200.0% during the 4th quarter. Global Retirement Partners LLC now owns 87 shares of the company’s stock valued at $37,000 after purchasing an additional 58 shares during the period. Finally, Rothschild Investment LLC lifted its holdings in shares of Chemed by 800.0% in the fourth quarter. Rothschild Investment LLC now owns 108 shares of the company’s stock valued at $46,000 after purchasing an additional 96 shares in the last quarter. 95.85% of the stock is currently owned by institutional investors and hedge funds.

Chemed Trading Down 0.2%

Shares of NYSE:CHE opened at $510.28 on Monday. The company has a market cap of $6.77 billion, a P/E ratio of 27.81, a P/E/G ratio of 1.88 and a beta of 0.52. The stock’s 50-day moving average is $458.59 and its 200-day moving average is $433.61. The company has a debt-to-equity ratio of 0.11, a quick ratio of 0.83 and a current ratio of 0.85. Chemed Corporation has a 52-week low of $365.20 and a 52-week high of $517.74.

Chemed (NYSE:CHE) last issued its quarterly earnings results on Thursday, April 23rd. The company reported $5.65 EPS for the quarter, topping the consensus estimate of $5.30 by $0.35. The company had revenue of $657.51 million for the quarter, compared to the consensus estimate of $659.22 million. Chemed had a return on equity of 27.18% and a net margin of 10.23%.The company’s revenue for the quarter was up 1.6% on a year-over-year basis. During the same period in the previous year, the business posted $5.63 EPS. Equities research analysts predict that Chemed Corporation will post 22.67 earnings per share for the current year.

Chemed Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, June 16th. Stockholders of record on Thursday, May 28th were given a dividend of $0.60 per share. The ex-dividend date was Thursday, May 28th. This represents a $2.40 dividend on an annualized basis and a dividend yield of 0.5%. Chemed’s payout ratio is currently 13.08%.

Analyst Ratings Changes

A number of brokerages have commented on CHE. Zacks Research upgraded Chemed from a “strong sell” rating to a “hold” rating in a research report on Monday, April 27th. Royal Bank Of Canada upped their target price on Chemed from $422.00 to $436.00 and gave the company a “sector perform” rating in a report on Monday, April 27th. Wall Street Zen lowered shares of Chemed from a “buy” rating to a “hold” rating in a research report on Monday, June 8th. Weiss Ratings upgraded shares of Chemed from a “hold (c-)” rating to a “hold (c)” rating in a report on Friday, July 17th. Finally, Bank of America raised their price target on shares of Chemed from $450.00 to $510.00 and gave the stock a “neutral” rating in a report on Thursday, July 9th. One investment analyst has rated the stock with a Buy rating and five have issued a Hold rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus price target of $480.25.

Insider Buying and Selling

In other news, Director Andrea R. Lindell sold 1,347 shares of the stock in a transaction that occurred on Tuesday, June 9th. The stock was sold at an average price of $447.33, for a total value of $602,553.51. Following the completion of the transaction, the director directly owned 4,578 shares of the company’s stock, valued at approximately $2,047,876.74. This represents a 22.73% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, CEO Kevin J. Mcnamara sold 2,000 shares of Chemed stock in a transaction on Friday, May 1st. The shares were sold at an average price of $421.13, for a total value of $842,260.00. Following the transaction, the chief executive officer directly owned 90,219 shares of the company’s stock, valued at approximately $37,993,927.47. The trade was a 2.17% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders own 3.33% of the company’s stock.

Chemed Profile

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.